Dr. David R. Elmaleh

Dr. Elmaleh is a veteran scientist, inventor, and entrepreneur who also serves as Associate Professor at Harvard Medical School and Director of Contrast Media Chemistry at Massachusetts General Hospital. His work has led to approved treatments representing over a billion dollars in shareholder value. He was named by Genetic Engineering & Biotechnology News to the 2014 list of “Biotech’s Most Enterprising Entrepreneurs” Prior to founding and serving as a Chairman of LizAI Inc., Dr. Elmaleh founded and led multiple diagnostic and pharmaceutical biotech companies, naming Molecular Insight (formerly Biostream), Mersana (formerly NanoPharma), Puretech Health, AZTherapies, Xylex, Atroo and recently CyberAra, a cybersecurity company.